Sharma Pragya, Sinha Rashmi, Prasad Anupa, Mitra J K
Department of Medicine, Rajendra Institute of Medical Sciences (RIMS), Ranchi, India.
Biochemistry Department, Rajendra Institute of Medical Sciences (RIMS), Ranchi, India.
J Thyroid Res. 2020 Sep 8;2020:8121395. doi: 10.1155/2020/8121395. eCollection 2020.
Hypothyroidism is a highly prevalent and multifactorial disorder and has been implicated in the causation of dyslipidemia, dermatological diseases, atherosclerosis, and myocardial dysfunction, as well as endothelial dysfunction. The relationship between subclinical hypothyroidism and type 2 diabetes mellitus is not well established. In the present study, we attempt to find out the prevalence of subclinical hypothyroidism in type 2 diabetes mellitus and its association with glycemic control.
This was an observational study in which 205 consecutive patients of T2DM visiting the outpatient department of medicine were recruited. Serum TSH, free thyroxine, free triiodothyronine, and lipid profile, as well as HbA1c assays, were done in the study participants, and they were categorized into three groups by HbA1c: <7%, 7-9%, and >9%.
There is a high prevalence of subclinical hypothyroidism in type 2 DM patients. Mean HbA1c in diabetics without SCH was 7.89%, whereas it was 8.33% in diabetics with SCH. This difference was statistically not significant. TSH was not found to be significantly associated with HbA1c.
High prevalence of SCH in T2DM patients suggests that there is a need for regular follow-up to check the progression of SCH to overt hypothyroidism. High serum TSH is not a predictor of poor glycemic control.
甲状腺功能减退症是一种高度流行的多因素疾病,与血脂异常、皮肤病、动脉粥样硬化、心肌功能障碍以及内皮功能障碍的发生有关。亚临床甲状腺功能减退症与2型糖尿病之间的关系尚未明确。在本研究中,我们试图找出2型糖尿病中亚临床甲状腺功能减退症的患病率及其与血糖控制的关系。
这是一项观察性研究,连续招募了205名到内科门诊就诊的2型糖尿病患者。对研究参与者进行血清促甲状腺激素(TSH)、游离甲状腺素、游离三碘甲状腺原氨酸、血脂谱以及糖化血红蛋白(HbA1c)检测,并根据HbA1c将他们分为三组:<7%、7 - 9%和>9%。
2型糖尿病患者中亚临床甲状腺功能减退症的患病率很高。无亚临床甲状腺功能减退症的糖尿病患者平均HbA1c为7.89%,而有亚临床甲状腺功能减退症的糖尿病患者平均HbA1c为8.33%。这种差异在统计学上不显著。未发现TSH与HbA1c有显著相关性。
2型糖尿病患者中亚临床甲状腺功能减退症的高患病率表明需要定期随访,以检查亚临床甲状腺功能减退症进展为显性甲状腺功能减退症的情况。血清TSH升高不是血糖控制不佳的预测指标。